Abstract
CaMBr1 is a blood group-related tumour-associated antigen, whose pattern of expression provides a therapeutic window for passive or active immunotherapy and points to the promise of a vaccine against carcinomas overexpressing this antigen. In this context, an animal model that closely mimics the human situation would be extremely useful. We, therefore, utilised the murine monoclonal antibody MBr1, which defines CaMBr1, as a useful probe to detect the molecule targeted for vaccine development on canine and feline spontaneous breast and uterus tumours and on their normal counterparts, and on rat normal tissues and carcinoma cell lines. Immunoperoxidase staining of cryostat sections revealed homogeneous CaMBr1 expression only in normal feline uterus and a uterus papilloma, whereas MBr1 reactivity was very weak and heterogeneous in normal (1/3 and 1/3) and tumour (1/10 and 1/6) breast tissues from dogs and cats, respectively. In contrast, the data obtained in rat tissues were reproducible in the strains tested and showed that CaMBr1 was expressed in all epithelial tissues of the digestive tract, although with variable intensities. Monoclonal antibody staining appeared to correspond to membrane-bound structures as well as mucinous secretions. Similarly, secretion products of lactating mammary glands expressed CaMBr1. The spectrum of expression on rat digestive tract was broader than that in humans but the specificity of MBr1 reactivity was confirmed by competition assay with a synthetic tetrasaccharide that mimics the CaMBr1 antigen. On FACS analysis, only one of two clonal derivatives of the rat breast carcinoma line RAMA 25 expressed CaMBr1, and a negative cell subset was evident in repeated experiments. By contrast, both colon carcinoma lines, DHD/K12 and CC531, showed staining with MBr1, albeit at different levels of intensity, and no evidence of a negative subset. The cell line CC531 maintained or even increased CaMBr1 expression levels following transplantation in syngeneic immunocompetent animals. Our data suggest the usefulness of the rat as a test model for vaccines against human cancers overexpressing the CaMBr1 antigen.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References cited
Adobati E, Panza L, Russo G, Colnaghi MI, Canevari S (1997) In vitro mimicry CaMBr1 tumor-associated antigen by synthetic oligosaccharides. Glycobiology 7: 173-178.
Breimer ME, Hansson GC, Karlsson K-A, Leffler H (1982) Glycosphingolipids of rat tissues. Different composition of epithelial and nonepithelial cells of small intestine. J Biol Chem 257: 557-568.
Bremer EG, Levery SB, Sonnino S, Ghidoni R, Canevari S, Kannagi R, Hakomori S (1984) Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland. J Biol Chem 259: 14773-14777.
Cascinelli N, Doci R, Belli F, Nava M, Marolda R, Costa A, Ménard S, Terno G (1986) Evaluation of toxic effects following administration of monoclonal antibody MBr1 in patients with breast cancer. Tumori 72: 267-271.
Clemo FAS, Denicola DB, Morrison WB, Carlton WW (1995) Immunoreactivity of canine epithelial and nonepithelial neoplasms with monoclonal antibody B72.3. Vet Pathol 32: 147-154.
Colombo MP, Forni G (1997) Immunotherapy. I: Cytokine gene transfer strategies. Cancer Metastasis Rev 16: 421-432.
Dulbecco R, Bologna M, Unger M (1979) Differentiation of a rat mammary cell line in vitro. Proc Natl Acad Sci USA 76: 1256-1260.
Falini B, Flenghi L, Fagioli M, Stein H, Schwarting R, Riccardi C, Manocchio I, Pileri S, Pelicci PG, Lanfrancone L (1989) Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognized by the ki-67 monoclonal antibody. J Histochem Cytochem 37: 1471-1478.
Galili U (1993) Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody. Springer Semin Immunopathol 15: 155-171.
Galili U, Swanson K (1991) Gene sequences suggest inactivation of alpha-1,3-galactosyltransferase in catarrhines after the divergence of apes from monkeys. Proc Natl Acad Sci USA 88: 7401-7404.
Greiner JW, Guadagni F, Noguchi P, Pestka S, Colcher D, Fisher PB, Schlom J (1987) Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo. Science 235: 895-898.
Hakomori S (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 56: 5309-5318.
Hansson GC, Bouhours J-F, Angstrom J (1987) Characterization of neutral blood group B-active glycosphingolipids of rat gastric mucosa. A novel type of blood group active glycosphingolipid based on isogloboside. J Biol Chem 262: 13135-13141.
Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J Histochem Cytochem 19: 577-580.
Lay L, Nicotra F, Panza L, Russo G, Adobati E (1994) Oligosaccharides related to tumor-associated antigens (Part 1′) Synthesis of the propyl glycoside of the trisaccharide α-L-Fucp-(1–2)-β-D-Galp-(1–3)-β-DGalpNAc, component of a tumor antigen recognized by the antibody MBr1. Helv Chim Acta 77: 509-514.
Lay L, Panza L, Russo G, Colombo D, Ronchetti F, Adobati E, Canevari S (1995) Oligosaccharides related to tumor-associate antigens (Part 3′) Synthesis of the propyl glycosides of the trisaccharide β-D-Galp-(1–3)-β-D-GalpNAc-(1–3)-α-D-Galp and of the tetrasaccharide α-L-Fucp-(1–2)-β-D-Galp-(1–3)-β-D-GalpNAc-(1–3)-α-DGalp, components of a tumor antigen recognized by the antibody MBr1. Helv Chim Acta 78: 533-538.
Mariani-Costantini R, Barbanti P, Colnaghi MI, Ménard S, Clemente C, Rilke F (1984a) Reactivity of a monoclonal antibody with tissues and tumors from human breast: Immunohistochemical localization of a new antigen and clinico-pathologic correlations. Am J Pathol 115: 47-56.
Mariani-Costantini R, Colnaghi MI, Leoni F, Ménard S, Cerasoli S, Rilke F (1984b) Immunohistochemical reactivities of a monoclonal antibody prepared against human breast carcinoma. Virchows Arch [A] 402: 389-404.
Marquet RL, Westbroek DL, Jeekel J (1984) Interferon treatment of a transplantable rat colon adenocarcinoma: Importance of tumor site. Int J Cancer 33: 689-692.
Martignone S, Ménard S, Bedini A, Paccagnella A, Fasolato S, Veggian R, Colnaghi MI (1993) Study of the expression and function of the tumor-associated antigen CaMBr1 in small cell lung carcinomas. Eur J Cancer 29A: 2020-2025.
Martin MS, Martin R, Michiels R, Bastien H (1973) An experimental model for cancer of the colon and rectum. Digestion 8: 22-34.
Ménard S, Tagliabue E, Canevari S, Fossati G, Colnaghi MI (1983) Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res 43: 1295-1300.
Miotti S, Leoni F, Canevari S, Sonnino S, Colnaghi MI (1989) Immunoblotting detection of carbohydrate epitopes in glycolipids and glycoproteins of tumoral origin. In: Oettgen HF, ed. Gangliosides and Cancer. Weinheim: VCH Verlagsgesellschaft, pp 169-176.
Mottolese M, Morelli L, Agrimi U, Benevolo M, Sciarretta F, Antonucci G, Natali PG (1994) Spontaneous canine mammary tumors. A model for monoclonal antibody diagnosis and treatment of human breast cancer. Lab Invest 71: 182-187.
Nouwen EJ, Dawne S, De Broe ME (1990) Occurrence of the mucinous differentiation antigen CA125 in genital tract and conductive airway epithelia of diverse mammalian species (rabbit, dog, monkey). Differentiation 45: 192-198.
Pastan I, Lovelace ET, Gallo MG, Rutherford AV, Magnani JL, Willingham MC (1991) Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res 51: 3781-3787.
Perrone F, Ménard S, Canevari S, Calabrese M, Boracchi P, Bufalino R, Testori S, Baldini M, Colnaghi MI (1993) Prognostic significance of the CaMBr1 antigen on breast carcinoma: Relevance of the type of recognised glycoconjugate. Eur J Cancer [A] 29A: 2113-2117.
Perrone F, Ménard S, Da Dalt MG, Leoni F, Di Palma S, Patriarca C, Rilke F, Colnaghi MI (1990) Expression of two antigens defined by monoclonal antibodies in normal, benign and malignant human mammary tissues. Tumori 76: 525-529.
Steimer KS, Klagsbrun M (1981) Serum-free growth of normal and transformed fibroblasts in milk: Differential requirements for fibronectin. J Cell Biol 88: 294-300.
Thomas C, Nijenhuis AM, Timens W, Kuppen PJK, Daemen T, Scherphof GL (1993) Liver metastasis model of colon cancer in the rat: Immunohistochemical characterization. Inv Metastasis 13: 102-112.
Toma L, Colombo D, Ronchetti F, Panza L, Russo G (1995) Oligosaccharides related to tumor-associate antigens Part 4 Modeling of the terminal tetrasaccharide of an antigen recognized by the MBr1 antibody and of overlapping di-and tri-saccharide sequences. Helv Chim Acta 78: 636-646.
Trail PA, Willner D, Lasch SJ, Henderson AJ, Hofstead S, Casazza AM, Firestone RA, Hellström I, Hellström KE (1993) Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science 261: 212-215.
Viale G, Grassi F, Pelagi M, Alzani R, Ménard S, Miotti S, Buffa R, Gini A, Siccardi AG (1987) Anti-human tumor antibodies induced in mice and rabbits by ‘internal image’ anti-idiotypic monoclonal immunoglobulins. J Immunol 139: 4250-4255.
World Health Organization (1974) International histological classification of tumors of domestic animals. World Health Organization, Geneva, Switzerland 53: 1-2.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adobati, E., Zacchetti, A., Perico, M.E. et al. Expression Profile of Saccharide Epitope CaMBr1 in Normal and Neoplastic Tissue from Dogs, Cats, and Rats: Implication for the Development of Human-derived Cancer Vaccines. Histochem J 31, 729–737 (1999). https://doi.org/10.1023/A:1003900631953
Issue Date:
DOI: https://doi.org/10.1023/A:1003900631953